Study: Experimental COVID Shot Made via Egg-Based Technology Elicits Higher Antibody Proportion than mRNA Vax – MedicalXpress 3/16/23


An experimental COVID-19 vaccine produced with technology based on a decades-old method, elicited virus-neutralizing antibodies in higher proportion than the amount induced by mRNA immunizations, a Phase 1 clinical trial has found.

The investigational vaccine was developed in New York City and tested in Thailand where the shots were produced using a form of egg-based technology. The fact that researchers are still racing to develop new COVID-19 vaccines highlights an ongoing need, especially in low- and —and for good reason….

Read More…